When was Stereotaxis founded?

Stereotaxis was founded in 1990 and raised its 1st funding round 8 years after it was founded.

Where is Stereotaxis located?

Stereotaxis is headquartered in St. Louis, United States. It is registered at St. Louis.

How many employees does Stereotaxis have?

As of Jul 31, 2026, the latest employee count at Stereotaxis is 193.

Is Stereotaxis a funded company?

Stereotaxis is a funded company, having raised a total of $52M across 7 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Aug 02, 1998.

When was the latest funding round of Stereotaxis?

Stereotaxis' latest funding was a $***** Post IPO round on May 26, 2020, with participation from 1 investor. Its primary sector is Surgical Instruments. In United States, the Surgical Instruments sector has seen $185M in funding in 2026 to date.

What is the annual revenue of Stereotaxis?

Annual revenue of Stereotaxis is between $10M and $50M as on Dec 31, 2025

Where does Stereotaxis rank among its competitors?

Stereotaxis ranks 7th amongst 260 active competitors, of which 105 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Levita Magnetics, which secured $30.7M in Feb, 2026.

Who are the top competitors of Stereotaxis?

Stereotaxis' top competitors include Intuitive, Medical Microinstruments and PROCEPT BioRobotics. Among them, Levita Magnetics secured the most recent funding round in February, 2026.

Stereotaxis - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Surgical robotics company advancing minimally invasive endovascular intervention for improved patient care. It pioneers and globally leads in surgical robotics for minimally invasive endovascular intervention. The mission centers on discovering, developing, and delivering robotic systems, instruments, and information solutions for the interventional laboratory. These innovations empower physicians to provide exceptional patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance productivity, connectivity, and intelligence in the operating room. They focus on robotic magnetic navigation, cardiac ablation, electrophysiology, and endovascular procedures. The company aims to revolutionize surgical practice through innovation and technology, improving outcomes for patients with heart rhythm disorders and other endovascular conditions.

Website: www.stereotaxis.com/
Social
Email ID: *****@stereotaxis.com
Registered Address: St. Louis

Key Metrics

Founded Year

1990

Location

St. Louis, United States

Stage

Public

Total Funding

$52M in 7 rounds

Latest Funding Round

Post IPO, May 26, 2020, $*****

Investors

Ascension Ventures & 9 more

Ranked

7^th among 260 active competitors

Annual Revenue

$10M - $50M as on Dec 31, 2025

Employee Count

193 as on Jul 31, 2026

Investment & Acquisitions

Robocath

Similar Companies

Intuitive & 281 more

Exit Details

Public

View Stereotaxis' full profile

Stereotaxis is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Stereotaxis, Inc CIN: 94-3120386 , Belgium, Active	Dec 31, 1989	-	130 (As on Dec 31, 2021)	-
Stereotaxis, Inc. CIN: 1289340 , United States, Active	Jun 12, 1990	$10M - $50M (As on Dec 31, 2025)	122 (As on Dec 31, 2023)	-

Stereotaxis got listed on Aug 12, 2004.

Click here to take a look at Stereotaxis's IPO in detail

Stereotaxis has raised a total funding of $52M over 7 rounds. Its first funding round was on Aug 02, 1998. Its latest funding round was a Post IPO round on May 26, 2020 for $*****. 1 investor participated in its latest round. Stereotaxis has 10 institutional investors.

Here is the list of recent funding rounds of Stereotaxis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 26, 2020	8964052	Post IPO	8893734	3271442	1672211	4811464
Aug 20, 2019	6585298	Post IPO	3923063	3247336	2918958	8363138
Oct 04, 2016	1483098	Post IPO	3637579	4023250	2693296	2955159

Access funding benchmarks and valuations. Sign up today!

View details of Stereotaxis's funding rounds and investors

The founders of Stereotaxis is William C Mills.

Here are the details of Stereotaxis' key team members:

William C Mills: Founder,Former Director and Chairman of the Board of Stereotaxis.

View details of Stereotaxis's Founder profiles and Board Members

Stereotaxis' employee count trend

Stereotaxis has 193 employees as of Jul 26. Here is Stereotaxis's employee count trend over the years:

Uncover Stereotaxis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Stereotaxis include Intuitive, Medical Microinstruments and PROCEPT BioRobotics. Here is the list of Top 10 competitors of Stereotaxis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Intuitive 1995, Sunnyvale (United States), Public	Developer of robotic-assisted surgical systems	$22M	Gershon Capital, ELM Responsible Investments ... & 11 others	77/100
2nd	Medical Microinstruments 2015, Calci (Italy), Series C	Provider of robotic platform using micro instruments for surgery	$210M	Fidelity Investments, Deerfield & 11 others	70/100
3rd	PROCEPT BioRobotics 2009, Redwood City (United States), Public	Developer of a therapeutic device for benign prostatic hyperplasia	$349M	Fidelity Investments, Novo Holdings & 6 others	70/100
4th	eCential Robotics 2009, Gieres (France), Series C	Manufacturer of surgical robotic systems for bone and orthopedic procedures	$110M	Bpifrance, BNP Paribas & 9 others	68/100
5th	Vicarious Surgical 2014, Boston (United States), Public	Provider of VR-based surgical robotic system for physicians	$43.2M	Innovation Endeavors, Khosla Ventures & 17 others	66/100
6th	CMR Surgical 2014, Cambridge (United Kingdom), Series D	Developer of collaborative surgical robotic systems	$1.28B	ABB, SoftBank Vision Fund & 38 others	65/100
7th	Stereotaxis 1990, St. Louis (United States), Public	Surgical robotics company advancing minimally invasive endovascular intervention for improved patient care	$52M	Ascension Ventures, Oakwood Medical & 8 others	64/100
8th	Neocis 2012, Miami (United States), Series D	Provider of robotic guidance system for dental surgeries	$179M	DFJ Growth, Norwest & 12 others	63/100
9th	Levita Magnetics 2011, San Mateo (United States), Series D	Developer of robotic surgical devices	$57.7M	Invermaster, BAMCAP & 8 others	62/100
10th	Robocath 2009, Rouen (France), Acquired	Developer of robotic solutions to treat cardiovascular diseases	$57.9M	GO CAPITAL, M Capital & 18 others	62/100